CN107308496A - 一种生物性组织加固支架材料及其制备方法 - Google Patents
一种生物性组织加固支架材料及其制备方法 Download PDFInfo
- Publication number
- CN107308496A CN107308496A CN201710432590.9A CN201710432590A CN107308496A CN 107308496 A CN107308496 A CN 107308496A CN 201710432590 A CN201710432590 A CN 201710432590A CN 107308496 A CN107308496 A CN 107308496A
- Authority
- CN
- China
- Prior art keywords
- animal derived
- extracellular matrix
- timbering material
- derived extracellular
- biological tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 110
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims abstract description 41
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims abstract description 41
- 210000002744 extracellular matrix Anatomy 0.000 claims abstract description 41
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 33
- 238000011282 treatment Methods 0.000 claims abstract description 25
- 210000001519 tissue Anatomy 0.000 claims abstract description 23
- 241001465754 Metazoa Species 0.000 claims abstract description 22
- 238000004108 freeze drying Methods 0.000 claims abstract description 22
- 210000004027 cell Anatomy 0.000 claims abstract description 20
- 230000001413 cellular effect Effects 0.000 claims abstract description 19
- 238000005238 degreasing Methods 0.000 claims abstract description 6
- 239000012528 membrane Substances 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 47
- 238000006243 chemical reaction Methods 0.000 claims description 25
- 239000007864 aqueous solution Substances 0.000 claims description 22
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 230000001954 sterilising effect Effects 0.000 claims description 20
- 238000004659 sterilization and disinfection Methods 0.000 claims description 19
- 210000003516 pericardium Anatomy 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 210000000813 small intestine Anatomy 0.000 claims description 11
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 241001494479 Pecora Species 0.000 claims description 9
- 150000001718 carbodiimides Chemical group 0.000 claims description 8
- 230000036541 health Effects 0.000 claims description 8
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 7
- 239000004593 Epoxy Substances 0.000 claims description 7
- 239000001263 FEMA 3042 Substances 0.000 claims description 7
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 7
- 229920002258 tannic acid Polymers 0.000 claims description 7
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 7
- 229940033123 tannic acid Drugs 0.000 claims description 7
- 235000015523 tannic acid Nutrition 0.000 claims description 7
- 210000004379 membrane Anatomy 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 238000003763 carbonization Methods 0.000 claims description 2
- 150000002466 imines Chemical class 0.000 claims description 2
- VZRRCQOUNSHSGB-UHFFFAOYSA-N 4-hydroxy-4,6,6-trimethylbicyclo[3.1.1]heptan-3-one Chemical compound C1C2C(C)(C)C1CC(=O)C2(O)C VZRRCQOUNSHSGB-UHFFFAOYSA-N 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 230000035479 physiological effects, processes and functions Effects 0.000 claims 1
- 125000003367 polycyclic group Chemical group 0.000 claims 1
- 238000004132 cross linking Methods 0.000 abstract description 25
- 230000002787 reinforcement Effects 0.000 abstract description 16
- 230000008929 regeneration Effects 0.000 abstract description 10
- 238000011069 regeneration method Methods 0.000 abstract description 10
- 239000004971 Cross linker Substances 0.000 abstract description 9
- 230000004927 fusion Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 230000035484 reaction time Effects 0.000 abstract description 5
- 230000007547 defect Effects 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 150000002632 lipids Chemical class 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000007788 liquid Substances 0.000 description 10
- 210000003786 sclera Anatomy 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000002513 implantation Methods 0.000 description 7
- 208000001491 myopia Diseases 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 238000004513 sizing Methods 0.000 description 7
- 230000004402 high myopia Effects 0.000 description 6
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 5
- 108010019160 Pancreatin Proteins 0.000 description 5
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 230000004379 myopia Effects 0.000 description 5
- 229940055695 pancreatin Drugs 0.000 description 5
- 210000004876 tela submucosa Anatomy 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 231100000053 low toxicity Toxicity 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 210000001525 retina Anatomy 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- -1 Geniposide glycoside Chemical class 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000035965 Postoperative Complications Diseases 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000036632 reaction speed Effects 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 238000009966 trimming Methods 0.000 description 2
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 206010060872 Transplant failure Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000515 collagen sponge Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004340 degenerative myopia Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- NGPZJQXXJCDBDS-UHFFFAOYSA-N dodecane-1-sulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCS(O)(=O)=O NGPZJQXXJCDBDS-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- BXKDSDJJOVIHMX-UHFFFAOYSA-N edrophonium chloride Chemical compound [Cl-].CC[N+](C)(C)C1=CC=CC(O)=C1 BXKDSDJJOVIHMX-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 201000001670 scleral staphyloma Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000717 sertoli cell Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3695—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710432590.9A CN107308496B (zh) | 2017-06-09 | 2017-06-09 | 一种生物性组织加固支架材料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710432590.9A CN107308496B (zh) | 2017-06-09 | 2017-06-09 | 一种生物性组织加固支架材料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107308496A true CN107308496A (zh) | 2017-11-03 |
CN107308496B CN107308496B (zh) | 2020-08-04 |
Family
ID=60183155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710432590.9A Active CN107308496B (zh) | 2017-06-09 | 2017-06-09 | 一种生物性组织加固支架材料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107308496B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110353857A (zh) * | 2019-01-30 | 2019-10-22 | 张亚平 | 眼后巩膜加固术用生物补片及其制备方法 |
CN110353856A (zh) * | 2019-01-30 | 2019-10-22 | 张亚平 | 一种眼后巩膜加固术用生物补片及其制备方法 |
CN110354310A (zh) * | 2019-01-30 | 2019-10-22 | 张亚平 | 后巩膜加固术用生物补片及其制备方法 |
CN110624132A (zh) * | 2019-09-20 | 2019-12-31 | 四川大学华西医院 | 一种膀胱修复支架材料及其制备方法和用途 |
WO2020057414A1 (zh) * | 2018-09-19 | 2020-03-26 | 杭州启明医疗器械股份有限公司 | 一种可快速吸水展平的干燥生物心脏瓣膜及其制备方法 |
CN112870444A (zh) * | 2021-01-25 | 2021-06-01 | 上海翰凌医疗器械有限公司 | 一种改性生物组织材料及其制备方法 |
CN113975465A (zh) * | 2021-10-19 | 2022-01-28 | 吾奇生物医疗科技(江苏)有限公司 | 一种基于动物组织的低温脱脂方法及其应用 |
CN115737925A (zh) * | 2022-08-08 | 2023-03-07 | 诺一迈尔(苏州)医学科技有限公司 | 一种巩膜加固材料及其制备方法和用途 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1416876B1 (en) * | 2001-07-16 | 2011-03-23 | DePuy Products, Inc. | Porous delivery scaffold and method |
CN102462561A (zh) * | 2010-11-19 | 2012-05-23 | 北京迈迪顶峰医疗科技有限公司 | 一种sis软组织修复补片及其制备方法 |
CN102525729A (zh) * | 2012-02-02 | 2012-07-04 | 温州医学院附属眼视光医院 | 一种高度近视后巩膜加固术生物膜材料条带及其制作方法 |
CN102793593A (zh) * | 2012-09-03 | 2012-11-28 | 于好勇 | 用于后巩膜加固术的异种巩膜片及其制备方法 |
WO2013035957A1 (ko) * | 2011-09-09 | 2013-03-14 | 아주대학교 산학협력단 | 생체내 분해기간이 조절 가능한 생체적합성 소장점막하조직 하이드로젤의 제조방법 |
CN104958791A (zh) * | 2015-07-29 | 2015-10-07 | 陕西博与再生医学有限公司 | 一种青光眼外科手术用复合生物基质及其制备方法 |
CN106267346A (zh) * | 2016-08-10 | 2017-01-04 | 苏州恒瑞迪生医疗科技有限公司 | 一种同时处理多种生物组织的方法 |
-
2017
- 2017-06-09 CN CN201710432590.9A patent/CN107308496B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1416876B1 (en) * | 2001-07-16 | 2011-03-23 | DePuy Products, Inc. | Porous delivery scaffold and method |
CN102462561A (zh) * | 2010-11-19 | 2012-05-23 | 北京迈迪顶峰医疗科技有限公司 | 一种sis软组织修复补片及其制备方法 |
WO2013035957A1 (ko) * | 2011-09-09 | 2013-03-14 | 아주대학교 산학협력단 | 생체내 분해기간이 조절 가능한 생체적합성 소장점막하조직 하이드로젤의 제조방법 |
CN102525729A (zh) * | 2012-02-02 | 2012-07-04 | 温州医学院附属眼视光医院 | 一种高度近视后巩膜加固术生物膜材料条带及其制作方法 |
CN102793593A (zh) * | 2012-09-03 | 2012-11-28 | 于好勇 | 用于后巩膜加固术的异种巩膜片及其制备方法 |
CN104958791A (zh) * | 2015-07-29 | 2015-10-07 | 陕西博与再生医学有限公司 | 一种青光眼外科手术用复合生物基质及其制备方法 |
CN106267346A (zh) * | 2016-08-10 | 2017-01-04 | 苏州恒瑞迪生医疗科技有限公司 | 一种同时处理多种生物组织的方法 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020057414A1 (zh) * | 2018-09-19 | 2020-03-26 | 杭州启明医疗器械股份有限公司 | 一种可快速吸水展平的干燥生物心脏瓣膜及其制备方法 |
CN110353857A (zh) * | 2019-01-30 | 2019-10-22 | 张亚平 | 眼后巩膜加固术用生物补片及其制备方法 |
CN110353856A (zh) * | 2019-01-30 | 2019-10-22 | 张亚平 | 一种眼后巩膜加固术用生物补片及其制备方法 |
CN110354310A (zh) * | 2019-01-30 | 2019-10-22 | 张亚平 | 后巩膜加固术用生物补片及其制备方法 |
CN110353856B (zh) * | 2019-01-30 | 2023-04-28 | 张亚平 | 一种眼后巩膜加固术用生物补片及其制备方法 |
CN110624132A (zh) * | 2019-09-20 | 2019-12-31 | 四川大学华西医院 | 一种膀胱修复支架材料及其制备方法和用途 |
CN112870444A (zh) * | 2021-01-25 | 2021-06-01 | 上海翰凌医疗器械有限公司 | 一种改性生物组织材料及其制备方法 |
CN113975465A (zh) * | 2021-10-19 | 2022-01-28 | 吾奇生物医疗科技(江苏)有限公司 | 一种基于动物组织的低温脱脂方法及其应用 |
CN115737925A (zh) * | 2022-08-08 | 2023-03-07 | 诺一迈尔(苏州)医学科技有限公司 | 一种巩膜加固材料及其制备方法和用途 |
CN115737925B (zh) * | 2022-08-08 | 2024-01-16 | 诺一迈尔(苏州)医学科技有限公司 | 一种巩膜加固材料及其制备方法和用途 |
WO2024032284A1 (zh) * | 2022-08-08 | 2024-02-15 | 诺一迈尔(苏州)医学科技有限公司 | 一种巩膜加固材料及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN107308496B (zh) | 2020-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107308496A (zh) | 一种生物性组织加固支架材料及其制备方法 | |
US10426868B2 (en) | Method for preparing an animal decellularized tissue matrix material and a decellularized tissue matrix material prepared thereby | |
CN104971380B (zh) | 一种脱细胞基质修复凝胶及其制备新方法 | |
CA2804592C (en) | Method for shaping tissue matrices | |
KR101894485B1 (ko) | 황화나트륨 용액을 이용한 동물 진피로부터의 이식물 제조 | |
CN101947144B (zh) | 一种板层组织工程角膜支架及其制作方法与应用 | |
CN100360190C (zh) | 具有生物活性的人工生物瓣瓣膜的制备方法 | |
CN102188748B (zh) | 一种新型软骨细胞外基质膜及其制备方法 | |
BR112013026200A2 (pt) | método para preparar uma composição de matriz de tecido, e matriz de tecido | |
CN101537207B (zh) | 一种组织工程化异种皮的制备方法 | |
CN101917932A (zh) | 处理猪角膜以脱细胞的方法 | |
CN104001214A (zh) | 一种板层角膜基质支架及其制备方法和应用 | |
CN107744413A (zh) | 新型带瓣血管的制备方法 | |
CN102793593B (zh) | 用于后巩膜加固术的异种巩膜片及其制备方法 | |
CN105963787A (zh) | 新型生物补片的制备方法 | |
CN108144124A (zh) | 一种脱细胞异体真皮基质及在口腔疾病中的应用 | |
CN111686301B (zh) | 一种高度透明的脱细胞角膜基质及其制备方法 | |
CN100484497C (zh) | 一种具有生物活性的人工角膜的制备方法 | |
CN107890586B (zh) | 一种同种异体生物乳房补片的制备方法 | |
CN113476667A (zh) | 一种鱼皮脱细胞真皮基质支架及其制备方法和应用 | |
CN105833357B (zh) | 一种易保存生物羊膜的制备方法 | |
CN105492034A (zh) | 用于组织产物的酶处理的方法 | |
WO2018107482A1 (zh) | 一种脱细胞猪角膜的制备方法及其脱细胞板层角膜和用法 | |
CN111035807A (zh) | 一种超薄apcs植片的制备方法 | |
CN103301507B (zh) | 一种人工生物肌腱及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A biological tissue reinforcement scaffold material and its preparation method Effective date of registration: 20230322 Granted publication date: 20200804 Pledgee: Industrial and Commercial Bank of China Limited Guangzhou tianpingjia sub branch Pledgor: GUANGZHOU YUEQING REGENERATION MEDICINE TECHNOLOGY Co.,Ltd. Registration number: Y2023980035710 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20200804 Pledgee: Industrial and Commercial Bank of China Limited Guangzhou tianpingjia sub branch Pledgor: GUANGZHOU YUEQING REGENERATION MEDICINE TECHNOLOGY Co.,Ltd. Registration number: Y2023980035710 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A biological tissue reinforcement scaffold material and its preparation method Granted publication date: 20200804 Pledgee: Industrial and Commercial Bank of China Limited Guangzhou tianpingjia sub branch Pledgor: GUANGZHOU YUEQING REGENERATION MEDICINE TECHNOLOGY Co.,Ltd. Registration number: Y2024980006559 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |